We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:
Medicine & public health

Search Results

Showing 1-20 of 8,513 results

  1. Lymphoproliferative disorder during temozolomide therapy; a representative case of a formidable complication and management challenges

    Background

    Lymphoproliferative disorder represents a heterogeneous clinicopathological spectrum characterized by uncontrolled proliferation of...

    Daisuke Sato, Hirokazu Takami, ... Nobuhito Saito in BMC Neurology
    Article Open access 09 June 2023

  2. Temozolomide

    in Reactions Weekly
    Article 16 March 2024

  3. Cordycepin improves sensitivity to temozolomide in glioblastoma cells by down-regulating MYC

    Purpose

    Glioblastoma is one of the malignant tumors with poor prognosis and no effective treatment is available at present.

    Methods

    To study the...

    Shi-**ng Zheng, **g Chen, ... Guo-Liang Zhang in Journal of Cancer Research and Clinical Oncology
    Article 11 September 2023

  4. Temozolomide

    in Reactions Weekly
    Article 08 June 2024

  5. Temozolomide

    in Reactions Weekly
    Article 01 June 2024

  6. Temozolomide

    in Reactions Weekly
    Article 27 April 2024

  7. A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma

    Purpose

    The optimal duration of post-radiation temozolomide in newly diagnosed glioblastoma remains unclear, with no published phase III randomised...

    L. Gately, C. Mesía, ... C. Balana in Journal of Neuro-Oncology
    Article 28 December 2023

  8. Temozolomide

    in Reactions Weekly
    Article 02 December 2023

  10. Temozolomide

    in Reactions Weekly
    Article 26 August 2023

  13. Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial

    Purpose

    In the randomized phase III trial CeTeG/NOA-09, temozolomide (TMZ)/lomustine (CCNU) combination therapy was superior to TMZ in newly diagnosed...

    J. Weller, N. Schäfer, ... C. Seidel in Journal of Neuro-Oncology
    Article Open access 07 January 2023

  16. Temozolomide

    in Reactions Weekly
    Article 22 June 2024

  18. Temozolomide

    in Reactions Weekly
    Article 06 April 2024
Did you find what you were looking for? Share feedback.